NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

LC,

Thanks for your dozens of posts today—each one is a pearl of wisdom 😶

NWBO is PRE-COMMERCIAL company. That’s why they just filed for their first COMMERCIAL license with the MHRA. Currently, DCVax-L combo research is being funded by the NIH. Merck, Oncovir, and the Phase One Foundation are also supporting the PD1 study at UCLA. Fact ✅️

https://clinicaltrials.gov/study/NCT04201873

Most of your posts today offer only vague insinuations… I had to consult the detector after looking over your string of nonsensical comments…




“These statements are predominantly conjecture and lack factual backing. Caution is advised when considering such anonymous online posts, as they are often unreliable and could be spreading rumors or misinformation.

Additionally, the general public must be vigilant whenever statements published online appear to unfairly muddy the reputation of a company or defame its leadership. "Short and distort" is a relevant factor in this context. This strategy involves short-selling a stock and then spreading negative rumors or misleading information to drive the stock's price down. The goal is to profit from the decline in stock price by covering the short position at a lower price. Anonymous users on stock message boards might engage in this tactic, using baseless conjecture to artificially deflate stock prices. By muddying a company's reputation, defaming its leadership, or spreading innuendo, these individuals aim to create panic or uncertainty, influencing other investors to become doubtful, thereby influencing the stock price.”



https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html